Detrimental Effects of Tobacco: Indian Lawyers Sue Government

Regulations by 2FIRSTS.ai
Jan.03.2024
Detrimental Effects of Tobacco: Indian Lawyers Sue Government
Indian lawyers sue government over lack of control on drug and tobacco addiction among youth.

According to an expose by Indian media outlet Mid-day on January 2, two lawyers in Mumbai have filed a lawsuit against the Indian government for its alleged failure to regulate the accessibility of drugs and tobacco, as well as the increasing addiction among young people. The legal notice emphasizes the adverse effects and health hazards of tobacco and highlights the government's inability to control its illegal sale.

 

Lawyers Abid Abbas Sayyed and Saif Alam have issued legal notices to the Chief Minister of Maharashtra, Health Minister, Mumbai Police Commissioner, and the Indian FDA.

 

The notice emphasizes the adverse effects, health hazards, and addictive nature associated with tobacco and highlights the failure to control its illegal sales. Lawyers have urged the government to pay attention to the sale of smuggled cigarettes from abroad and the supply of banned Gutkha (a type of Indian tobacco product).

 

According to survey data, India has approximately 275 million tobacco users, with 35% of the population being 15 years old or older. Of particular concern is the increasing use of tobacco in developing countries, which has contributed significantly to the burden of tobacco-related diseases and premature deaths. The rapid increase in tobacco use among children, adults, and other vulnerable groups in society has raised significant concerns in terms of public health at both local and national levels.

 

Saiyifu stated that the 1975 Cigarettes (Production, Supply and Distribution Regulation) Act mandated the inclusion of statutory health warnings on all cigarette packaging and advertisements. However, the 1975 Cigarettes Act was found to be flawed due to its limited scope and weak provisions. Subsequently, the Cigarettes and Other Tobacco Products Act of 2003 (Prohibition of Advertisement and Regulation of Trade and Commerce, Production, Supply and Distribution) (COTPA) was introduced.

 

Saif said that COTPA is the primary law in India for tobacco control management, providing a more comprehensive approach covering all tobacco products, including cigarettes.

 

The purpose of this law is to safeguard and enhance public health by adopting evidence-based strategies to reduce tobacco consumption. This legislation was approved by India on February 5, 2004, prior to the World Health Organization (WHO) Tobacco Control Framework Convention.

 

In a major move by the government of Maharashtra, as part of the anti-tobacco campaign, the production, sale, and distribution of gutka and tobacco have been prohibited. These items fall under the purview of the Food Safety and Standards Act (FSSA) of 2006.

 

Aram stated that the ban was implemented in July 2012 and the decision was upheld by the Mumbai High Court, receiving further support and extending the ban in Maharashtra until July 2014.

 

Two individuals quoted the 2016-17 Global Adult Tobacco Survey in their notification, emphasizing that a quarter of adolescents in Maharashtra state consume tobacco. Advocate Aram stated, "According to data from the Health and Services Department, from 2016 to March 2022, hospitals and centers in Maharashtra have registered approximately one million patients with a history of tobacco consumption.

 

Alam and Sayeed have requested the police to develop an appropriate action plan through a legal notice and have called on the state government to establish new legislation.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
Earnings Analysis | CTIHK H1 2026 Revenue Falls 26.9% as Core Businesses Diverge and New Growth Drivers Remain to Be Proven
China Tobacco International (HK) reported a 26.9% revenue decline in H1 2026, while gross profit fell only 9.5%, revealing sharp divergence across its businesses. Tobacco leaf imports contracted, while leaf exports and Brazil operations expanded strongly. Cigarette exports faced China duty-free market transition, and new tobacco products remained small. Meanwhile, CTIHK continues to strengthen its role as an investment and financing platform, though major external deals have yet to emerge. 2Firsts examines what these shifts mean for its next growth drivers.
Capital Markets
Aug.24
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
Trump Picks White House Health Policy Aide Heidi Overton to Lead FDA, Pending Senate Confirmation
U.S. President Donald Trump has chosen White House health policy aide Heidi Overton to lead the Food and Drug Administration, Bloomberg reported, citing a person familiar with the matter. Overton currently works on health policy at the White House and previously held a senior role at the America First Policy Institute. If confirmed by the Senate, she would take over an FDA that has experienced months of senior-level turnover. The agency regulates products representing roughly one-fifth of U.S. consumer spending, including e-cigarettes, drugs, vaccines and much of the food supply.
News
Aug.19
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company Launches Flavored Vuse Pro Pods in U.S. Without FDA Marketing Authorization
R.J. Reynolds Vapor Company has begun selling four flavored Vuse Pro pods — Peach, Berry, Watermelon and Fresh Mint — in Ohio and selected other U.S. markets. According to the Vuse U.S. FAQ, Vuse Pro contains approximately 5.0% nicotine by weight, and Vuse Pro pre-filled pods are intended for use with Vuse Alto devices. Reynolds told 2Firsts that product labeling lists an e-liquid capacity of 2.0 mL per pod. The Vuse Alto Power Unit received FDA marketing authorization in 2024, while the new Vuse Pro pods themselves have not received marketing granted orders. The rollout follows the FDA’s May 2026 revision of enforcement priorities for certain unauthorized vaping products with qualifying pending applications.
BAT
Sep.10
UK HMRC Issues One-Month Countdown Warning, Urges Vape Businesses to Prepare for New Tax Rules
UK HMRC Issues One-Month Countdown Warning, Urges Vape Businesses to Prepare for New Tax Rules
The UK’s Vaping Products Duty and Vaping Duty Stamps Scheme will take effect on October 1, 2026. All vaping liquids manufactured in or imported into the UK will face a flat excise duty of £2.20 per 10ml, whether or not they contain nicotine. Newly manufactured or imported products released onto the UK market from October 1 will require a valid duty stamp, while eligible existing unstamped inventory can continue to be sold through March 31, 2027. From April 1, 2027, all vaping products outside duty suspension must carry a valid stamp.
Sep.03
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India Steps Up Nicotine Pouch Enforcement as ZYN, White Fox Circulate and Drug Panel Urges Halt to New Nicotine Formulations
India's Ministry of Health and Family Welfare has directed states to step up enforcement against nicotine pouch sales, citing increased availability through online and offline channels and concern about nicotine exposure among children. Reuters reported that international brands including ZYN and White Fox are being sold in India. A study led by ICMR-NICPR found pouches in seven of 10 surveyed locations and identified 68 brands and 445 flavors online. Separately, India's Drugs Technical Advisory Board recommended in August that no new nicotine formulation be approved.
Regulations
Sep.28 by 2Firsts Perspectives
Imperial Brands Plans Thousands of Job Cuts Across U.S. and Europe in Cost Restructuring
Imperial Brands Plans Thousands of Job Cuts Across U.S. and Europe in Cost Restructuring
According to Reuters, citing Bloomberg News, British tobacco company Imperial Brands PLC plans to cut thousands of jobs across the United States and Europe as part of a cost reduction and organizational restructuring effort. The announcement drew market attention to the company’s shares. The move comes as global tobacco companies continue adjusting their operations amid slower cigarette market growth, changing consumer preferences and the transition toward next-generation nicotine products.
Aug.11